New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 9, 2012
09:14 EDTINCYIncyte initiated with a Buy at Guggenheim
Target $27.
News For INCY From The Last 14 Days
Check below for free stories on INCY the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 24, 2014
07:16 EDTINCYIncyte weakness a buying opportunity, says Oppenheimer
Oppenheimer believes the risk/reward ratio for the data that Incyte will present at ASCO is positive. The firm adds that the ASCO data could provide significant positive catalysts for the stock. It keeps a $75 price target and Outperform rating on the shares.
April 16, 2014
08:34 EDTINCYPiper Jaffray tech and biopharma analysts hold analyst/industry conference call
Technical Analyst Johnson, along with BioPharma Analysts, discuss the recent downturn in the biotech and specialty pharmaceuticals industries on an Analyst/Industry conference call to be held on April 17 at 10 am.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use